Skip to main content

Peer Review reports

From: Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry

Original Submission
9 Oct 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
10 Nov 2022 Reviewed Reviewer Report
19 Nov 2022 Reviewed Reviewer Report
21 Nov 2022 Reviewed Reviewer Report
10 Dec 2022 Author responded Author comments - Xiaojin Gao
Resubmission - Version 3
10 Dec 2022 Submitted Manuscript version 3
14 Dec 2022 Author responded Author comments - Xiaojin Gao
Resubmission - Version 4
14 Dec 2022 Submitted Manuscript version 4
15 Dec 2022 Author responded Author comments - Xiaojin Gao
Resubmission - Version 5
15 Dec 2022 Submitted Manuscript version 5
20 Dec 2022 Reviewed Reviewer Report
25 Dec 2022 Reviewed Reviewer Report
1 Feb 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
2 Feb 2023 Editorially accepted
22 Feb 2023 Article published 10.1186/s12872-023-03105-1

You can find further information about peer review here.

Back to article page